![Trinity Place Holdings Inc (PK)](/common/images/company/NO_TPHS.png)
Ionis reports second quarter 2024 financial results PR Newswire CARLSBAD, Calif., Aug. 1, 2024 WAINUATM U.S. launch progressing well; approved in Canada; EU approval decision expected this...
Alcyone Therapeutics Announces Continued Enrollment Approval from FDA of the PIERRE Pivotal IDE Clinical Study of the ThecaFlex DRx™ System for Administration of nusinersen PR Newswire LOWELL...
Ionis announces positive detailed results from the HALOS Study of ION582 in people with Angelman syndrome PR Newswire CARLSBAD, Calif., July 22, 2024 ION582 showed robust and consistent benefit...
Ionis to hold second quarter 2024 financial results webcast PR Newswire CARLSBAD, Calif., July 19, 2024 Webcast scheduled for Thursday, August 1 at 11:30 a.m. Eastern Time CARLSBAD, Calif., July...
Ionis completes enrollment in pivotal trial evaluating zilganersen in people living with Alexander disease PR Newswire CARLSBAD, Calif., July 18, 2024 Zilganersen is the first investigational...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.008 | 16 | 0.05 | 0.069 | 0.0425 | 4149012 | 0.0561 | CS |
4 | 0.008 | 16 | 0.05 | 0.069 | 0.0425 | 4149012 | 0.0561 | CS |
12 | 0.008 | 16 | 0.05 | 0.069 | 0.0425 | 4149012 | 0.0561 | CS |
26 | 0.008 | 16 | 0.05 | 0.069 | 0.0425 | 4149012 | 0.0561 | CS |
52 | 0.008 | 16 | 0.05 | 0.069 | 0.0425 | 4149012 | 0.0561 | CS |
156 | 0.008 | 16 | 0.05 | 0.069 | 0.0425 | 4149012 | 0.0561 | CS |
260 | 0.008 | 16 | 0.05 | 0.069 | 0.0425 | 4149012 | 0.0561 | CS |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約